InnovAge (NASDAQ:INNV) Stock Breaks Above Fifty Day Moving Average - Time to Sell?

InnovAge logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • InnovAge shares moved above their 50-day moving average, trading as high as $9.74 and last at $9.58, versus a 50-day average of $9.49.
  • Analysts’ consensus rating is Hold, with an average price target of $10.50; recent ratings ranged from Sell to Strong Buy, and KeyCorp raised its target to $14.
  • The company beat quarterly estimates, reporting EPS of $0.14 versus $0.09 expected and revenue of $264.76 million versus $257.23 million expected. Insiders sold about 13 million shares worth $120.5 million in the last quarter.
  • Five stocks we like better than InnovAge.

InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $9.49 and traded as high as $9.74. InnovAge shares last traded at $9.58, with a volume of 281,329 shares changing hands.

Analysts Set New Price Targets

A number of research firms recently issued reports on INNV. Weiss Ratings upgraded InnovAge from a "sell (d-)" rating to a "hold (c-)" rating in a research note on Wednesday, November 4th. KeyCorp boosted their price objective on InnovAge from $13.00 to $14.00 and gave the company an "overweight" rating in a research note on Wednesday, September 9th. Finally, Wall Street Zen raised InnovAge from a "buy" rating to a "strong-buy" rating in a report on Saturday, November 7th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, InnovAge currently has a consensus rating of "Hold" and an average target price of $10.50.

Get Our Latest Research Report on InnovAge

InnovAge Price Performance

The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.16 and a current ratio of 1.16. The company has a market capitalization of $1.31 billion, a PE ratio of 159.67 and a beta of 0.16. The company's 50-day simple moving average is $9.49 and its 200-day simple moving average is $9.23.

InnovAge (NASDAQ:INNV - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.05. InnovAge had a net margin of 0.88% and a return on equity of 3.63%. The business had revenue of $264.76 million during the quarter, compared to analysts' expectations of $257.23 million. As a group, sell-side analysts anticipate that InnovAge Holding Corp. will post 0.44 earnings per share for the current year.

Insider Activity at InnovAge

In other InnovAge news, major shareholder Aggregator Lp Ignite sold 10,000,000 shares of the company's stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $9.25, for a total transaction of $92,500,000.00. Following the completion of the sale, the insider directly owned 102,576,555 shares of the company's stock, valued at $948,833,133.75. This represents a 8.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole Damato sold 23,814 shares of the company's stock in a transaction that occurred on Friday, September 25th. The shares were sold at an average price of $8.70, for a total value of $207,181.80. Following the sale, the insider directly owned 304,897 shares of the company's stock, valued at approximately $2,652,603.90. This represents a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,027,216 shares of company stock worth $120,489,535 in the last quarter. Company insiders own 1.10% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of INNV. BlackRock Inc. acquired a new stake in shares of InnovAge during the second quarter worth $17,652,000. Goldman Sachs Group Inc. increased its stake in InnovAge by 207.1% in the 3rd quarter. Goldman Sachs Group Inc. now owns 668,219 shares of the company's stock valued at $5,880,000 after buying an additional 450,610 shares during the period. Algert Global LLC increased its stake in InnovAge by 844.1% in the 2nd quarter. Algert Global LLC now owns 630,520 shares of the company's stock valued at $7,472,000 after buying an additional 563,735 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in InnovAge in the 1st quarter valued at $3,349,000. Finally, Marshall Wace LLP purchased a new position in InnovAge during the 3rd quarter worth $3,589,000. Institutional investors and hedge funds own 12.26% of the company's stock.

InnovAge Company Profile

(Get Free Report)

InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge's services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines